Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials-MedSci.cn

Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials

Zhao, D; Zeng, LF; Liang, GH; Pan, JK; Luo, MH; Han, YH; Liu, J; Yang, WY

Yang, WY (通讯作者)，Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China.;Liu, J (通讯作者)，Guangdong Prov Acad Chinese Med Sci, Bone & Joint Res Team Degenerat & Injury, Guangzhou, Peoples R China.;Liu, J (通讯作者)，Guangdong Second Tradit Chinese Med Hosp, Guangdong Prov Engn Technol Res Inst Tradit Chine, Guangzhou, Peoples R China.;Liu, J (通讯作者)，Guangzhou Univ Chinese Med, Clin Med Coll 5, Guangzhou, Peoples R China.

Abstract

center dot Purpose: Considering the adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids for treating osteoarthritis (OA), dev......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials

科室

工具

服务